ArticleFrontiers in psychiatry2022

Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance.

Haishan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.